Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 552-558

  Liu, Jing ^a,b   Grundy, Scott M ^b   Wang, Wei ^a   Smith Jr , Sidney C ^c   Lena Vega, Gloria ^b   Wu, Zhaosu ^a   Zeng, Zhechun ^a   Wang, Wenhua ^a   Zhao, Dong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ADULT; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; RISK FACTORS; TIME FACTORS;

EID: 33947305997     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.003     Document Type: Article

References (30)

1. Truelsen T., Mahonen M., Tolonen H., et al. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke 34 (2003) 1346-1352
2. He J., Gu D., Wu X., et al. Major causes of death among men and women in China. N Engl J Med 353 (2005) 1124-1134
3. Wang Y., Mi J., Shan X.Y., et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 31 (2007) 177-188
4. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
5. Kahn R., Buse J., Ferrannini E., et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
6. Alexander C.M., Landsman P.B., Teutsch S.M., et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
7. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 385-390
8. Malik S., Wong N.D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
9. Liu J., Hong Y., D'Agostino Sr. R.B., et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291 (2004) 2591-2599
10. Wu Z., Yao C., Zhao D., et al. A prospective cohort study on cardiovascular disease incidence in 11 provinces of China, I: associations between risk factor level and cardiovascular disease incidence. Chin J Cardiol 27 (1999) 5-8
11. MONICA Manual, Part IV: event Registration. (Accessed May 8, 2006, at http://www.ktl.fi/publications/monica/manual/part4/iv-1.htm).
12. Wu Z., Yao C., Zhao D., et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China. Part I: morbidity and mortality monitoring. Circulation 103 (2001) 462-468
13. Gutzwiller F. Monitoring of cardiovascular disease and risk factor trends: experiences from the WHO/MONICA project. Ann Med 26 (1994) 61-65
14. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
15. Liu J., Grundy S.M., Wang W., et al. Ethnic-specific criteria for the metabolic syndrome: evidence from China. Diabetes Care 29 (2006) 1414-1416
16. Meigs J.B., Nathan D.M., D'Agostino Sr. R.B., et al. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25 (2002) 1845-1850
17. Wei M., Gaskill S.P., Haffner S.M., et al. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21 (1998) 1167-1172
18. Hu F.B., Stampfer M.J., Solomon C.G., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161 (2001) 1717-1723
19. Howard B.V., Best L.G., Galloway J.M., et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 29 (2006) 391-397
20. Stern M.P., Williams K., and Hunt K.J. Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease. Atheroscler Suppl 6 (2005) 3-6
21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
22. Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 (2003) 383-393
23. Li L., Rao K., Kong L., et al. A description on the Chinese National Nutrition and Health Survey in 2002. Chin J Epidemiol 26 (2005) 478-484
24. Wang W., Zhao D., Liu J., et al. A prospective study of relationship between blood pressure and 10-year cardiovascular risk in a Chinese cohort aged 35-64 years. Chin J Intern Med 34 (2004) 730-734
25. Zhang Y., Lee E.T., Devereux R.B., et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 47 (2006) 410-414
26. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 158 (1998) 1855-1867
27. Schulze M.B., Shai I., Manson J.E., et al. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes. Diabetologia 47 (2004) 2129-2136
28. Athyros V.G., Papageorgiou A.A., Mercouris B.R., et al. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 18 (2002) 220-228
29. Wilson P.W., D'Agostino R.B., Parise H., et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
30. Wildman R.P., Gu D., Reynolds K., et al. Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults?. Am J Clin Nutr 82 (2005) 1195-1202